{"id":1018685,"date":"2026-11-09T07:55:34","date_gmt":"2026-11-09T12:55:34","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-november-and-december-investor-conferences\/"},"modified":"2026-11-09T07:55:34","modified_gmt":"2026-11-09T12:55:34","slug":"bridgebio-to-participate-in-november-and-december-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-november-and-december-investor-conferences\/","title":{"rendered":"BridgeBio to Participate in November and December Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>PALO ALTO, Calif., Nov.  09, 2026  (GLOBE NEWSWIRE) &#8212; BridgeBio Pharma, Inc. (Nasdaq: BBIO) (\u201cBridgeBio\u201d or the \u201cCompany\u201d), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for genetic conditions, today announced that members of its management team will participate in fireside chats at the following healthcare investor conferences:<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>Jefferies Global Healthcare Conference, London, UK:<\/strong> Monday, November 16 at 9:30 am GMT<\/li>\n<li>\n          <strong>Evercore ISI 9th Annual Healthcare Conference, Miami, FL:<\/strong> Monday, November 30 at 2:35 pm EST<\/li>\n<li>\n          <strong>Citi Global Healthcare Conference 2026, Miami, FL:<\/strong> Tuesday, December 1 at 3:00 pm EST<\/li>\n<li>\n          <strong>Piper Sandler 38<\/strong><br \/>\n          <sup><br \/>\n            <strong>th<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual Healthcare Conference, New York, NY:<\/strong> Wednesday, December 2 at 9:30 am EST<\/li>\n<\/ul>\n<p>To access the live webcast of BridgeBio\u2019s presentations, please visit the \u201cEvents and Presentations\u201d page within the Investors section of the BridgeBio website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GWn_50yJ9rCs0NJ-GBh8VToPG1fKwi4ZneyaR_whzildx82X7Cy0CSPAvQ3gZpv1wUtJaVOLfPsXx3aAiiGOftW164NK86CWqLts3hzHA18Ob3ONPTRj0QoGNGoDh8dQ\" rel=\"nofollow\" target=\"_blank\"><strong>https:\/\/investor.bridgebio.com<\/strong><\/a>. A replay of the webcasts will be available on the BridgeBio website for 30 days following the event.<\/p>\n<p>\n        <strong>About BridgeBio Pharma, Inc.<\/strong><br \/>\n        <br \/>BridgeBio exists to develop transformative medicines for genetic conditions. Millions of people worldwide living with genetic conditions lack treatment options, often because drug development for small patient populations can be commercially challenging. We aim to bridge the gap between advancements in genetic science and meaningful medicines for underserved patient populations. Our decentralized, hub-and-spoke model is designed for speed, precision, and scalability. Autonomous and empowered teams focus on individual conditions, while a central hub provides the clinical, regulatory, and commercial capabilities needed to bring innovation to market. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XImUQ1VpxR2Fgx-8bF5OK8sHSZZwhwcoUVBMuskqbSP4418fZoiCiKjITW1ae_kulfmAhWu5O5ZQjWtdrTg8KZqCl8bqZxIU6-Y7KReXUM2j7zJRru3CA8gP8nB7T0X8lJMwueAwsPufz8mMwC1ThGIgtwrYOqvJ9DXgdTpiAxTM25-s7kIL9wfIfqNEnq3RMvYWQpvOuy-JqHho3tGI0EHjRauvO_E8ZhCvcD7w7fWGFtmOyOjp1JABFO0ZoLmNGgH_gowKJav7xUXOIVmXGzC1gNDueEnkC9BoF4OPQoW6C9VWPFB3uucJfzfHncmdLV0OW2N4ZeDrw0MmhG98KxsbDB7N_bK9yJXFi3QIBfMINZ5I_mY0MIy2I1nzSM0HBzxO3ZBtb_pCrEvaB4bUoytRjfBb9EmR9lSGQERZ7Xj2Efs40s520c8rpjAXhbQ7ciCGzl6j9NeuCbDUPy6OtQ==\" rel=\"nofollow\" target=\"_blank\"><strong>bridgebio.com<\/strong><\/a> and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-UKQZse9sWnNsL1YKti3UDAkuLnJTO0rnJ_AU2BFzFyn6AL-kAF6mqSTDRzVmli1c62Duh9xfiHt7-wNN9hZMnNr4np-UsThTjeWFzk4m-wawuVZnkSCNpf7xll3DMQQkKYJj5VLNmwKrUv__hbQ90Lj4pOXfRIex0h97kGBVxwZp93KTGHcI393G6SVZPza4gV2uVcbi1XPwTH8luMpA0Siq6HUTo3_Zw2IX8aElgQLHEcM2Ra2mss8qMgMoU-u4-nYCDGQFYA-mOe9MBWekw1_uOWJQ0a7_fOHq0i-labcLsLyUXG-8Bf01MmLnEifsP59b157j8OnWq3hekvy2xvDmyGoE2f-lAplaQ4qF5othRSw5cpmdE2d49VApw9n53XZlCZdVALv9rr7_vlbN1tqNM2adm86yObw-DK_v9C06PGbefJw4bB_1g9hT5_U\" rel=\"nofollow\" target=\"_blank\"><strong>LinkedIn<\/strong><\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=p2HtL3Z6WC7AKoOsqe5xOezztIh-Rhndiv17SBIq3Fs-ZNiSy8CMEqCBUQWn9hXolP1o_W-QVk7KTR0seTCeJmDI-c9N3fbPo7Y1peNVD_bVmV7jPJhGS2Na8wEgSQB1cIyh6ttxtksZcmOYaDCBbytD4IUYA927rqFZsoE0c7NgQaJxZ66lSRs-xKMHLgmKE-GR0HTz7Ff29NgueVV1z23wHPwzikbQLIkfhd8Ks-cjE2KZYLlAxECAeWa6zCaCf5RUbzJ146QlbSJ6ilR1iT20v7bTVeiBnnORnHRXu1vFpSG3f9Ie4sN2qQ5ZxXT99cGo8hTff9OONDId1gwe4u21IaaSe1rqqHtecuREPwNZj29jR3_SD5Sls5cRBxRy\" rel=\"nofollow\" target=\"_blank\"><strong>X<\/strong><\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=M1KFyMqxcNglbv_tnBYj6L0QwGMk3-24Cd6lgmZko9_Rn2AS8pUjh2IxGJtfneBFAWHRLk4fxoAT2O8NwioH7ykJaQcXLoJgQIP7q8y_NYUGpRxXNYd-iIJywOysALJJViK0OI5xVF0CZt2oQGQNSo_6j3U6SylL24DhuHWQJGrCYRjL3Ozh1ry2lB6wwswsBQV4TJaQeu1dK3XXCPVM3KEuEQX3KL8GfUd8I31inZtiLi4gisUXEJfWx3zvrRBRaok1wKf4jtN_7TMCFpuc0N4H9qukwW3fdGxtXm4Z-C0x0B8ItvK-lJp4JQ9OTtpSgxBSPoFOKVu2-9WAQDpIHKt9O5s783tSsnX8CAa5IK-KY7jDXFZ9ZCQUTqNClVeJxni2OI8qrGVciqKZeiloxODhdGJE0SSk3GsU3wGizLYbazLuU8rCOoE0ekuPiPTLxsSzLsqLB7BKwjyCXzPhBH_v8RuasgusC0ZshQc6f5s=\" rel=\"nofollow\" target=\"_blank\"><strong>Facebook<\/strong><\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=T63qMmhXISwnvJml9cB1H1yvMCbwM7wVbLnTrsTzbxyLt-3pD3_DKeytIHMhzKAvgroKEGRVcdIXW4lnD9b6GsDuc_Mkd3ZEsh0Fyh0AS78e-Z2aJiApPJA_K9BeH-TZvLmEUyIyL5IVjU9D-a0HnnjGgfRqsbWWVGPQDCsXA7CtShIncSU49ubBVwvkJC14KfMoIQFuDKp9UpDAwpyhX3PtKqd0_P2aGNxieLIw_p5Cs7AxG4xa84N_Cbs-mSWMH7QIYqA__hJ-Dmp_dyqqMxgF9ttN389f_G5NJU6Tvw0Ng12le5hdf_YuOYP9GsUhNDPvJ3y7SElW8PmoSeMPS51sYTpe24_S_tGC2CnMh91PiLHJaNIPbleiO_uI58b_9-uEwmkPmjb5D3LOxE87iy3GN5OBPnleGDLTpki00FyZ-uJ4O1-wjrUckKO1gZoc\" rel=\"nofollow\" target=\"_blank\"><strong>Instagram<\/strong><\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RoeH59o_k56CtTNi0RvVQ4EFYTiaFZdjdiYBvUFnl09TNWUYISbJr1GmD2z2fx33HrftSZf806UI_VIfcE8TupAq9tCSKt2zkwizVC3xUE7QgenUqXnqgTK84M-6Zz-tFtKvCErgQi7hM6PNKHhUE_VAygvurJpDpUUQ3jPBjKu0ZE9fivub3uYjFb3WqqX27QeHmSDMfbwAPQ94ltrro1MPaaHKiSZLMvK40FsKaY1Lv0c2UYZpYF7PkFg-Y4SdCGwdGnRDvodt4e-96NjOIOvxa8zmPMbJMJ-54DYthp7HX-m00TEXhatBKkMQsTf8qrfc-ZkgzB78_sI3eHw1424olNIuCzIeExjzi5o42QwtmNM1V8R0zHlJpoN4ajDcQP2Xn8ZFWEvX6tBKJ_MH83B6hltrsrVprQjm8e27XvoeckJWMZHuF-DxXTuDPzQ2\" rel=\"nofollow\" target=\"_blank\"><strong>YouTube<\/strong><\/a>, and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=maMfd7XFXALGBpLFT8zp-oBuBpd45_V_AHdUNu54ltpXQwAXBi6axvlLBOKjnnZyPXWanWjAva9fWTFpBDDTSKu70PKie4Y3TW9BWDKVKZjVIx9nF5oJdcfWOEjoYe953w8Iu5WhAG8ZwPmPvt8K6Tg2OGm4mOUV8k5Rm4emreyPCyfKewhEUuK7ZobU6Zr9tvJ86HZbedzQw9lXbtuoXpm4ft-jgAsRFMo1tGAFmqsPxfAVEcpRVFDaqZ4vcLMqzoxvjM6K5Ts6nHpgDDEj7YWQ_LDwQEPm8E9EX208wBQSxXQxsFb6HyQgk2ds2S2SyCF81rICNuUzvJkVpeXE_St1zqqUArKGd9eWmtERy-RQbX1Qri7dZ9jV9hMAqbNseU6vbxfpDdltRK6uxsfJu14X8gLm2qHNWPmFFSc11cuvcJccP5jtOUqcL8XTbB5J\" rel=\"nofollow\" target=\"_blank\"><strong>TikTok<\/strong><\/a>.<\/p>\n<p>\n        <strong>BridgeBio Media Contact:<\/strong><br \/>\n        <br \/>Kaitlyn Reilly, Director, Communications<br \/>contact@bridgebio.com\u00a0\u00a0 <br \/>(650)-789-8220<\/p>\n<p>\n        <strong>BridgeBio Investor Contact:<\/strong><br \/>\n        <br \/>BridgeBio Investor Relations<br \/>ir@bridgebio.com<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MjYwNCM3OTUxMDA1IzIxNTY5MjY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MzJhNWNkNDUtOTJmYi00ZTM1LTlkNzMtNDY2MTkyMGZhOGE4LTExNjg0OTctMjAyNi0xMS0wOS1lbg==\/tiny\/BridgeBio-Pharma-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PALO ALTO, Calif., Nov. 09, 2026 (GLOBE NEWSWIRE) &#8212; BridgeBio Pharma, Inc. (Nasdaq: BBIO) (\u201cBridgeBio\u201d or the \u201cCompany\u201d), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for genetic conditions, today announced that members of its management team will participate in fireside chats at the following healthcare investor conferences: Jefferies Global Healthcare Conference, London, UK: Monday, November 16 at 9:30 am GMT Evercore ISI 9th Annual Healthcare Conference, Miami, FL: Monday, November 30 at 2:35 pm EST Citi Global Healthcare Conference 2026, Miami, FL: Tuesday, December 1 at 3:00 pm EST Piper Sandler 38 th Annual Healthcare Conference, New York, NY: Wednesday, December 2 at 9:30 am EST To access the live webcast of BridgeBio\u2019s presentations, please visit the \u201cEvents &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-november-and-december-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BridgeBio to Participate in November and December Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1018685","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BridgeBio to Participate in November and December Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-november-and-december-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BridgeBio to Participate in November and December Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PALO ALTO, Calif., Nov. 09, 2026 (GLOBE NEWSWIRE) &#8212; BridgeBio Pharma, Inc. (Nasdaq: BBIO) (\u201cBridgeBio\u201d or the \u201cCompany\u201d), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for genetic conditions, today announced that members of its management team will participate in fireside chats at the following healthcare investor conferences: Jefferies Global Healthcare Conference, London, UK: Monday, November 16 at 9:30 am GMT Evercore ISI 9th Annual Healthcare Conference, Miami, FL: Monday, November 30 at 2:35 pm EST Citi Global Healthcare Conference 2026, Miami, FL: Tuesday, December 1 at 3:00 pm EST Piper Sandler 38 th Annual Healthcare Conference, New York, NY: Wednesday, December 2 at 9:30 am EST To access the live webcast of BridgeBio\u2019s presentations, please visit the \u201cEvents &hellip; Continue reading &quot;BridgeBio to Participate in November and December Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-november-and-december-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-09T12:55:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MjYwNCM3OTUxMDA1IzIxNTY5MjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-participate-in-november-and-december-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-participate-in-november-and-december-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BridgeBio to Participate in November and December Investor Conferences\",\"datePublished\":\"2026-11-09T12:55:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-participate-in-november-and-december-investor-conferences\\\/\"},\"wordCount\":277,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-participate-in-november-and-december-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MjYwNCM3OTUxMDA1IzIxNTY5MjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-participate-in-november-and-december-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-participate-in-november-and-december-investor-conferences\\\/\",\"name\":\"BridgeBio to Participate in November and December Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-participate-in-november-and-december-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-participate-in-november-and-december-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MjYwNCM3OTUxMDA1IzIxNTY5MjY=\",\"datePublished\":\"2026-11-09T12:55:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-participate-in-november-and-december-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-participate-in-november-and-december-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-participate-in-november-and-december-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MjYwNCM3OTUxMDA1IzIxNTY5MjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MjYwNCM3OTUxMDA1IzIxNTY5MjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bridgebio-to-participate-in-november-and-december-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BridgeBio to Participate in November and December Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BridgeBio to Participate in November and December Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-november-and-december-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"BridgeBio to Participate in November and December Investor Conferences - Market Newsdesk","og_description":"PALO ALTO, Calif., Nov. 09, 2026 (GLOBE NEWSWIRE) &#8212; BridgeBio Pharma, Inc. (Nasdaq: BBIO) (\u201cBridgeBio\u201d or the \u201cCompany\u201d), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for genetic conditions, today announced that members of its management team will participate in fireside chats at the following healthcare investor conferences: Jefferies Global Healthcare Conference, London, UK: Monday, November 16 at 9:30 am GMT Evercore ISI 9th Annual Healthcare Conference, Miami, FL: Monday, November 30 at 2:35 pm EST Citi Global Healthcare Conference 2026, Miami, FL: Tuesday, December 1 at 3:00 pm EST Piper Sandler 38 th Annual Healthcare Conference, New York, NY: Wednesday, December 2 at 9:30 am EST To access the live webcast of BridgeBio\u2019s presentations, please visit the \u201cEvents &hellip; Continue reading \"BridgeBio to Participate in November and December Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-november-and-december-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-09T12:55:34+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MjYwNCM3OTUxMDA1IzIxNTY5MjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-november-and-december-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-november-and-december-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BridgeBio to Participate in November and December Investor Conferences","datePublished":"2026-11-09T12:55:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-november-and-december-investor-conferences\/"},"wordCount":277,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-november-and-december-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MjYwNCM3OTUxMDA1IzIxNTY5MjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-november-and-december-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-november-and-december-investor-conferences\/","name":"BridgeBio to Participate in November and December Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-november-and-december-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-november-and-december-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MjYwNCM3OTUxMDA1IzIxNTY5MjY=","datePublished":"2026-11-09T12:55:34+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-november-and-december-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-november-and-december-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-november-and-december-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MjYwNCM3OTUxMDA1IzIxNTY5MjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MjYwNCM3OTUxMDA1IzIxNTY5MjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bridgebio-to-participate-in-november-and-december-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BridgeBio to Participate in November and December Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1018685","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1018685"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1018685\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1018685"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1018685"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1018685"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}